1. Home
  2. MRCY vs VKTX Comparison

MRCY vs VKTX Comparison

Compare MRCY & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercury Systems Inc

MRCY

Mercury Systems Inc

HOLD

Current Price

$80.76

Market Cap

5.0B

Sector

N/A

ML Signal

HOLD

VKTX

Viking Therapeutics Inc.

N/A

Current Price

$32.82

Market Cap

4.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MRCY
VKTX
Founded
1981
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
4.0B
IPO Year
1997
2014

Fundamental Metrics

Financial Performance
Metric
MRCY
VKTX
Price
$80.76
$32.82
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$80.00
$95.86
AVG Volume (30 Days)
774.5K
1.7M
Earning Date
05-05-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
23.08
N/A
EPS
N/A
N/A
Revenue
$983,622,000.00
N/A
Revenue This Year
$6.59
N/A
Revenue Next Year
$9.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.85
N/A
52 Week Low
$65.04
$22.96
52 Week High
$128.45
$43.15

Technical Indicators

Market Signals
Indicator
MRCY
VKTX
Relative Strength Index (RSI) 31.78 44.98
Support Level $71.60 $31.84
Resistance Level $88.06 $33.77
Average True Range (ATR) 3.99 1.44
MACD -0.96 0.03
Stochastic Oscillator 4.25 28.12

Price Performance

Historical Comparison
MRCY
VKTX

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Share on Social Networks: